maraviroc
General
Genetic Implications: 
Pronunciation: 
ma-ra-vi-rok
To hear audio pronunciation of this topic, purchase a subscription or log in.Trade Name(s)
- Celsentri 
 - Selzentry
 
Ther. Class.
Pharm. Class.
CCR5 co-receptor antagonists
There's more to see -- the rest of this topic is available only to subscribers.
Citation
Vallerand, April Hazard., et al. "Maraviroc." Davis's Drug Guide, 19th ed., F.A. Davis Company, 2025. Pediatrics Central, peds.unboundmedicine.com/pedscentral/view/Davis-Drug-Guide/109309/7/maraviroc. 
Vallerand AHA, Sanoski CAC,  . Maraviroc. Davis's Drug Guide. F.A. Davis Company; 2025. https://peds.unboundmedicine.com/pedscentral/view/Davis-Drug-Guide/109309/7/maraviroc. Accessed November 3, 2025.
Vallerand, A. H., Sanoski, C. A., & ,  (2025). Maraviroc. In Davis's Drug Guide (19th ed.). F.A. Davis Company. https://peds.unboundmedicine.com/pedscentral/view/Davis-Drug-Guide/109309/7/maraviroc
Vallerand AHA, Sanoski CAC,  . Maraviroc [Internet]. In: Davis's Drug Guide. F.A. Davis Company; 2025. [cited 2025 November 03]. Available from: https://peds.unboundmedicine.com/pedscentral/view/Davis-Drug-Guide/109309/7/maraviroc.
* Article titles in AMA citation format should be in sentence-case
TY  -  ELEC
T1  -  maraviroc
ID  -  109309
A1  -  Sanoski,Cynthia A,
AU  -  Vallerand,April Hazard,
AU  -  ,,
BT  -  Davis's Drug Guide
UR  -  https://peds.unboundmedicine.com/pedscentral/view/Davis-Drug-Guide/109309/7/maraviroc
PB  -  F.A. Davis Company
ET  -  19
DB  -  Pediatrics Central
DP  -  Unbound Medicine
ER  -  

Davis's Drug Guide

